ABSK021 Food Effect Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 23, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

May 26, 2023

Conditions

Neoplasms

Interventions

DRUG

ABSK021 with fed state

25 mg ABSK021 (1x25 mg ABSK021 capsule) with food

DRUG

ABSK021 with fasted state

25 mg ABSK021 (1x25 mg ABSK021 capsule) without food

Trial Locations (1)

Huashan Hospital Fudan University, Shanghai